Titan Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 408.55 million compared to INR 326.56 million a year ago. Revenue was INR 411.12 million compared to INR 328.22 million a year ago. Net income was INR 63.92 million compared to INR 72.1 million a year ago. Basic earnings per share from continuing operations was INR 7.74 compared to INR 8.72 a year ago. Diluted earnings per share from continuing operations was INR 7.74 compared to INR 8.72 a year ago. For the six months, sales was INR 822.95 million compared to INR 720.75 million a year ago. Revenue was INR 826.95 million compared to INR 724.74 million a year ago. Net income was INR 151.16 million compared to INR 199.49 million a year ago. Basic earnings per share from continuing operations was INR 18.29 compared to INR 24.14 a year ago. Diluted earnings per share from continuing operations was INR 18.29 compared to INR 24.14 a year ago.